Page last updated: 2024-08-23

idarubicin and Astrocytoma, Grade IV

idarubicin has been researched along with Astrocytoma, Grade IV in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (50.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (50.00)	2.80

Authors

Authors	Studies
Borecka, A; Kaczmarczyk, B; Kasperczyk, J; Marcinkowski, A; Paul-Samojedny, M; Stoklosa, K; Turek, A	1
Beijnen, JH; Boogerd, W; Tjahja, IS; van de Sandt, MM	1

Trials

1 trial(s) available for idarubicin and Astrocytoma, Grade IV

Article	Year
Penetration of idarubicin into malignant brain tumor tissue. Journal of neuro-oncology, 1999, Volume: 44, Issue:1 Topics: Administration, Oral; Antibiotics, Antineoplastic; Astrocytoma; Brain Neoplasms; Breast Neoplasms; Drug Administration Schedule; Glioblastoma; Humans; Idarubicin	1999

Other Studies

1 other study(ies) available for idarubicin and Astrocytoma, Grade IV

Article	Year
Designing Biodegradable Wafers Based on Poly(L-lactide-co-glycolide) and Poly(glycolide-co-ε-caprolactone) for the Prolonged and Local Release of Idarubicin for the Therapy of Glioblastoma Multiforme. Pharmaceutical research, 2020, May-07, Volume: 37, Issue:5 Topics: Cell Line, Tumor; Cell Survival; Drug Carriers; Drug Liberation; Glioblastoma; Humans; Idarubicin; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Technology, Pharmaceutical	2020

Article

Year

Designing Biodegradable Wafers Based on Poly(L-lactide-co-glycolide) and Poly(glycolide-co-ε-caprolactone) for the Prolonged and Local Release of Idarubicin for the Therapy of Glioblastoma Multiforme.

Pharmaceutical research, 2020, May-07, Volume: 37, Issue:5

Topics: Cell Line, Tumor; Cell Survival; Drug Carriers; Drug Liberation; Glioblastoma; Humans; Idarubicin; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Technology, Pharmaceutical

2020